Healthcare Chatbots Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

The overall healthcare chatbots market is projected to reach USD 381.3 million by 2030 from USD 127.0 million by 2020, at a CAGR of 21.8% during the forecast period.

Clear

Description

Healthcare Chatbots Market by Component (Software, Service), Deployment Model (Cloud, On-Premise), Application (Symptom Check, Medical Assistance, Appointment Booking), End User (Patient, Healthcare Providers, Insurance Companies) – Global Forecast to 2030
Product Overview
Chatbots is a software responsible for establishment of conversation between a human and artificial intelligence. Chatbots use textual or audio outputs to communicate with the customer. The conversation is carried out by using pre-calculated phrases in the form of texts. These chatbots are either cloud-based or on premise solutions, which are used by patients for checking symptoms, locating clinics or scheduling appointments. Furthermore, healthcare chatbots are also used by healthcare payers to establish a relation between the company and the potential customers.
Market Highlights
The overall healthcare chatbots market is projected to reach USD 381.3 million by 2030 from USD 127.0 million by 2020, at a CAGR of 21.8% during the forecast period. At present, chatbots are adopted among the developed countries such as North and Europe, and is yet to witness widespread adoption in emerging countries, where doctors and other healthcare providers are still reluctant to adopt advanced healthcare solutions.
Market Segmentations
Based on deployment, the cloud based segment occupied the largest share and is also the fastest growing segment during the forecast period owing to various advantages offered by these type of chatbots. For instance, cloud-based chatbots require less initial investment, they are more accessible and require less customization as compared to on premise based chatbots. Therefore, factors aforementioned contribute to healthcare chatbots market growth.
Market Dynamics
Optimum internet connectivity and rising adoption of smart devices will favor the growth of the healthcare chatbot solutions market
Rising internet connectivity and the growing adoption of smartphones and mobile platforms play a key role in ensuring the adoption and use of chatbots. This has ensured growing number of consumers to access healthcare services, and also greatly broadened the reach of said services. According to data published by Anthem Insurance Companies, Inc. (U.S.) in May 2017, approximately 50% of smartphone users gather health information using mobile apps; 36% of doctors say apps are the most effective way to engage with patients; and 90% of doctors believe mobile apps can improve health.
Technology advancement in artificial intelligence drives the healthcare chatbots market growth
Widespread advancements occurring in the field of artificial intelligence is primarily responsible for driving growth in the global healthcare chatbots market. This is mainly due to the implementation of more sophisticated and mature chatbot processes that are intensely smart to deal with engaging customers who intend to access healthcare services.
Regions
North America accounted for the major healthcare chatbots market share in 2018 and is expected to continue this trend owing to, easy availability of the healthcare chatbots service. Moreover, the long patient waiting time contribute to the growth of global healthcare chatbots market in North America. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period owing to surge in awareness related to the use of healthcare chatbots. The constantly evolving life science industry drives the growth of the market in the developing economies such as India, China, Malaysia, and others.
Key Players
• ealthTap, Inc.,
• Anboto
• Sensely
• Buoy Health, Inc.
• Infermedica
• Babylon
• Baidu, Inc.
• Ada Health GmbH
• PACT Care BV
• Woebot
• GYANT.COM, Inc.
• Creative Virtual
• Your.MD
• Synthetix Ltd.
• Next IT Corp.
• CX Company

Healthcare Chatbots Market Segments:
By Application
• Symptoms Check
• Medical & Drug Information Assistance
• Appointment Scheduling & Monitoring
• Other Applications
By Deployment
• Cloud-based
• On-premise
By End User
• Healthcare Providers
• Healthcare Payers
• Patients
• Other End Users

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Global Healthcare Chatbots Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Healthcare Chatbots Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Healthcare Chatbots Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Healthcare Chatbots Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Application: Market Share (2020-2030);
12.2.1. Symptoms Check, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Medical & Drug Information Assistance, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Appointment Scheduling & Monitoring, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Other, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Deployment: Market Share (2020-2030F)
12.3.1. Cloud-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. On-premise, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By End user: Market Share (2020-2030F)
12.4.1. Healthcare Providers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Healthcare Payers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Patients, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13 Company Profile
13.1. HealthTap, Inc.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Anboto
13.3. Sensely
13.4. Buoy Health, Inc.
13.5. Infermedica
13.6. Babylon
13.7. Baidu, Inc.
13.8. Ada Health GmbH
13.9. PACT Care BV
13.10. Woebot
13.11. GYANT.COM, Inc.
13.12. Creative Virtual
13.13. Other Prominent Players
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.